Lindsay A. Rosenwald M.D., Director at AVENUE THERAPEUTICS, INC. (ATXI), bought 348,675 shares at $0.72 ($251K) on 2023-09-08, disclosed to the SEC on 2023-09-12.
Open-market purchase of $251k ATXI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| FBIO | BUY | 2024-05-20 | $18K | — | Filing → |
| DERM | BUY | 2024-03-27 | $30K | — | Filing → |
| DERM | BUY | 2024-03-25 | $68K | — | Filing → |